Saxagliptin Plus Metformin Lowers HbA1C Levels Over Metformin Alone In Phase III Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Data involving 743 patients is the first Phase III data evaluating the DDP-4 inhibitor to be released by Bristol/AstraZeneca.